期刊文献+

低钠血症对慢性心力衰竭患者预后的影响 被引量:3

Prognostic value of hyponatremia in patients with chronic heart failure
下载PDF
导出
摘要 目的:探讨低钠血症对慢性心力衰竭(CHF)患者预后的影响。方法:按血钠水平86例CHF患者被分为正常 血钠组(52例)和低钠血症组(34例),按常规CHF治疗后,比较两组左室射分数(LVEF)、CHF纠正时间和死亡 率。结果:与正常血钠组比较,低钠血症组LVEF显著降低,心力衰竭纠正时间显著延长,死亡率显著升高(P均 <0.05)。结论:低钠血症是CHF患者影响预后的重要影响因素。 Objective: To investigate the prognostic value of hyponatremia in patients with chronic heart failure. Methods: According to their serum sodium levels, 86 patients were divided into two groups (52 cases with normal sodium, 34 cases with hyponatremia). Their ejection fraction of left ventricle (LVEF), improvement time of heart failure and mortality between two groups after routine treatment were compared. Results : The LVEF significantly decreased, the improvement time of heart failure increased and the mortality increased (P〈0.05 all) in hyponatremia group compared with normal sodium group. Conclusion: Hyponatremia is an important prognostic factor in patients with chronic heart failure.
作者 张红梅
出处 《心血管康复医学杂志》 CAS 2005年第6期529-530,共2页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 低钠血症 心力衰竭 充血性 死亡率 Hyponatremia Heart failure, congestive Mortality
  • 相关文献

参考文献6

  • 1Lee WH,Packer M.Prognostic importance of serum sodium concentrition and its modification by converting enzyme inhibition in patients with severe chronic heart failure[J].Circulation,1986,73 (3):257.
  • 2刘献,李卫,李丙鑫.充血性心衰患者尿Na^+/K^+比值和螺内酯应用的关系[J].心血管康复医学杂志,2002,11(4):331-333. 被引量:3
  • 3Panciroli C,Galloni G,Oddone A,et al.Prognostic value of hyponatremia in patients with severe chronic heart failure[J].Angiology,1990,41 (8):631-638.
  • 4张子彬.充血性心衰[M](第2版)[M].北京:科学技术出版社,1997.522-523.
  • 5许顶立,任昊.慢性心力衰竭水潴留机制的研究进展[J].第一军医大学学报,2001,21(1):65-67. 被引量:13
  • 6Szatalowicz VL,Arnold PE,Chaimovitz C,et al.Radioimmunoassay of plasma arginine vasoprassin in hyponatremia with congestive heart failure[J].N Engl J Med,1981,305:263:266.

二级参考文献15

  • 1许顶立 殷晓燕 等.尿液水通道蛋白2的临床检测[J].肾脏病与透析肾移植杂志,2000,9(4):396-8.
  • 2许项立,肾脏病与透析肾移植杂志,2000年,9卷,4期,396页
  • 3许项立,中华内科杂志,2000年,39卷,7期,471页
  • 4许项立,中华心血管病杂志,2000年,28卷,3期,218页
  • 5Martin P Y,J Am Soc Nephrol,1999年,10卷,10期,2165页
  • 6Rai T,J Am Soc Nephrol,1997年,8卷,6期,1357页
  • 7Xu D L,J Clin Invest,1997年,99卷,4期,1500页
  • 8Xu D L,J Am Soc Nephrol,1996年,7卷,Suppl期,1274页
  • 9vanVliet AA,Donker AJ, Nauta JJ,et al. Spironolactone in congestive heart falilure refractory to high-dosed loop diuretic and low dose angiotensin converting enzyme inhibitor[J].Am J Cardiol, 1993,71(3):21-28.
  • 10Han YL, Tong M, Jing QM,et al. Combined therapy of captopriland spironolactone for refractory congestive heart failure[J]. Chin J Med, (Engl),1994,107(9):688-692.

共引文献14

同被引文献41

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部